Literature DB >> 1748549

Cytoskeleton in normal and reactive human retinal pigment epithelial cells.

U Fuchs1, T Kivelä, A Tarkkanen.   

Abstract

The cytoskeleton of normal and reactive retinal pigment epithelium (RPE) was analyzed immunohistochemically in five light microscopically normal formalin-fixed, paraffin-embedded human eyes enucleated because of orbital tumor and in 44 eyes with a uveal melanoma. In 26 eyes, the RPE overlying the tumor was morphologically normal or atrophic; in 18 eyes, hyperplastic changes were present. Normal RPE cells lacked vimentin, but it was present in 35 of 44 eyes with uveal melanoma. Antibodies that recognize cytokeratins CK8 and CK18 labeled normal and reactive RPE cells in all specimens. Although CAM 5.2 and CY-90 detected RPE cells strongly and quantitatively, clones CK5, KS-B17.2, and pancytokeratin antibody lu-5 reacted weakly and did not label some specimens. Immunoblotting supported the presence of CK8 and CK18 in human RPE. Normal RPE cells did not express other simple epithelial cytokeratins, but both atrophic and hyperplastic reactive RPE cells were labeled with antibodies to CK7 or CK19 in 24 of the 44 eyes. Hyperplastic proliferating RPE cells that formed subretinal membranes reacted positively for alpha-smooth muscle actin in 13 of 18 eyes. Antibodies to CK8 and CK18 are valuable markers of normal and reactive human RPE cells, but a panel of reagents is necessary to document reactive changes in the cytoskeleton. Acquisition of alpha-smooth muscle actin by human RPE cells may be related to their ability to form periretinal membranes and contribute to intraocular proliferative diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748549

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

Review 1.  Retinoinvasive malignant melanoma of the uvea.

Authors:  T Kivelä; P Summanen
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

2.  Retinal pigment epithelial cells: autocrine and paracrine stimulation of extracellular matrix contraction.

Authors:  S Grisanti; P Esser; U Schraermeyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

3.  Cell types of secondary cataract: an immunohistochemical analysis with antibodies to cytoskeletal elements and macrophages.

Authors:  M Uusitalo; T Kivelä
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-08       Impact factor: 3.117

4.  Malignant tumor of the retinal pigment epithelium with extraocular extension in a phthisical eye.

Authors:  K U Loeffler; T Kivelä; H Borgmann; H Witschel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

5.  VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION.

Authors:  Emma C Zanzottera; Thomas Ach; Carrie Huisingh; Jeffrey D Messinger; Richard F Spaide; Christine A Curcio
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

6.  Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.

Authors:  Hemangi Patil; Arjun Saha; Eugene Senda; Kyoung-in Cho; MdEmdadul Haque; Minzhong Yu; Sunny Qiu; Dosuk Yoon; Ying Hao; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-09-03       Impact factor: 5.157

7.  The HNK-1 epitope in the inner connective tissue layer of the human ciliary body in exfoliation syndrome and various types of glaucoma.

Authors:  M Uusitalo; T Kivelä; A Tarkkanen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117

8.  An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.

Authors:  U Fuchs; T Kivelä; P Summanen; I Immonen; A Tarkkanen
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

9.  Cytokeratin-containing cells in proliferative diabetic retinopathy membranes.

Authors:  P Hiscott; R Gray; I Grierson; Z Gregor
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

10.  The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration.

Authors:  Anna Tsapara; Phillip Luthert; John Greenwood; Caroline S Hill; Karl Matter; Maria S Balda
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.